ScTIL（Beijing ChineoMedical Technology Co Ltd）

N/A

Report date: 2022/12/31 20:52:39

Base Information

Drug NameScTIL（Beijing ChineoMedical Technology Co Ltd）
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes
Mechanisms of ActionLymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsUrologic NeoplasmsGastrointestinal NeoplasmsDigestive System Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Chineo Medical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Chineo Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsUrologic NeoplasmsGastrointestinal NeoplasmsDigestive System Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A